abagovomab 27
abciximab 27
abituzumab 20
abrilumab 19
actoxumab 16
adalimumab 17
aducanumab 10
afasevikumab 17
alacizumab_pegol 12
alemtuzumab 22
alirocumab 18
amatuximab 35
andecaliximab 20
anifrolumab 21
anrukinzumab 18
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 22
ascrinvacumab 7
atezolizumab 15
atinumab 14
avelumab 13
basiliximab 26
bavituximab 35
begelomab 23
benralizumab 25
bevacizumab_beta 23
bezlotoxumab 16
bimagrumab 10
bleselumab 13
blinatumomab 33
blosozumab 27
bococizumab 17
brazikumab 15
brentuximab_vedotin 25
briakinumab 16
brodalumab 11
brolucizumab 26
brontictuzumab 24
burosumab 17
cabiralizumab 24
camrelizumab 14
canakinumab 24
cantuzumab_ravtansin 45
carlumab 14
carotuximab 27
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 43
citatuzumab_bogatox 26
cixutumumab 22
clivatuzumab_tetraxetan 18
codrituzumab 31
conatumumab 9
concizumab 32
crenezumab 20
crizanlizumab 23
crotedumab 19
dacetuzumab 21
daclizumab 10
dalotuzumab 36
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 9
demcizumab 21
denosumab 10
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 18
dinutuximab 36
diridavumab 15
domagrozumab 15
drozitumab 13
duligotuzumab 19
durvalumab 9
dusigitumab 11
efalizumab 29
efungumab 27
eldelumab 14
elezanumab 17
elgemtumab 11
elotuzumab 16
emactuzumab 18
emapalumab 25
emibetuzumab 16
enavatuzumab 24
enfortumab_vedotin 12
enoblituzumab 16
enokizumab 21
enoticumab 17
ensituximab 29
eptinezumab 17
erenumab 16
etaracizumab 18
etrolizumab 22
evinacumab 21
evolocumab 13
farletuzumab 14
fasinumab 20
fezakinumab 15
fibatuzumab 9
ficlatuzumab 18
firivumab 33
flanvotumab 17
fletikumab 18
foralumab 10
foravirumab 12
fremanezumab 28
fresolimumab 17
fulranumab 19
futuximab 26
galcanezumab 17
ganitumab 25
gantenerumab 11
gemetuzumab 24
gemtuzumab2 25
gemtuzumab 23
gevokizumab 23
girentuximab 30
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 24
ibritumomab 28
icrucumab 8
idarucizumab 34
ifabotuzumab 9
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 32
indusatumab 15
inebilizumab 29
intetumumab 13
iodine_girentuximab 28
ipilimumab 3
iratumumab 12
isatuximab 35
itolizumab 24
ixekizumab 31
labetuzumab_govitecan 19
lambrolizumab 26
lampalizumab 22
lanadelumab 17
landogrozumab 17
laprituximab 22
lebrikizumab 34
lendalizumab 22
lenzilumab 13
lifastuzumab_vedotin 25
ligelizumab 22
lilotomab 34
lirilumab 21
lodelcizumab 16
lokivetmab 25
lorvotuzumab_mertansin 26
lucatumumab 27
lumretuzumab 15
lupartumab 10
lutikizumab 21
margetuximab 33
milatuzumab 40
mirvetuximab 33
mirvetuximab_soravtansin 33
modotuximab 36
mogamulizumab 36
monalizumab 16
motavizumab 29
moxetumomab_pasudotox 32
namilumab 14
naratuximab 24
naratuximab_emtansin 24
narnatumab 15
navicixizumab2 26
navicixizumab 22
navivumab 34
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 12
obiltoxaximab 20
obinutuzumab 34
ocaratuzumab 25
ofatumumab 18
olaratumab 19
olokizumab 25
omalizumab 20
onartuzumab 21
ontuxizumab 22
opicinumab 14
orticumab 13
otelixizumab 37
oxelumab 11
ozanezumab 28
pamrevlumab 10
panobacumab 28
parsatuzumab 25
pasotuxizumab 20
pateclizumab 14
patritumab 18
pembrolizumab 26
perakizumab 21
pidilizumab 18
pinatuzumab_vedotin 18
plozalizumab 31
pogalizumab 22
polatuzumab_vedotin 20
ponezumab 36
prezalumab 12
pritoxaximab 29
quilizumab 21
racotumomab 27
radretumab 14
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 23
refanezumab 24
remtolumab 17
rilotumumab 17
rinucumab 18
risankizumab 34
rituximab 20
rivabazumab 17
robatumumab 20
roledumab 27
romosozumab 20
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 22
sacituzumab 26
sacituzumab_govitecan 26
samalizumab 22
sapelizumab 22
sarilumab 16
secukinumab 10
seribantumab 17
setoxaximab 43
sifalimumab 8
siltuximab 25
simtuzumab 26
sirukumab 10
solanezumab 25
solitomab 23
stamulumab 15
suptavumab 22
suvizumab 18
tabalumab 10
tadocizumab 14
tamtuvetmab 30
tanezumab 21
tarextumab 11
tavolixizumab 17
telisotuzumab 25
teplizumab 19
tesidolumab 18
tezepelumab 22
tigatuzumab 17
tildrakizumab 18
timolumab 15
tisotumab 13
tosatoxumab 32
tositumomab 28
tralokinumab 23
trastuzumab 22
tregalizumab 24
trevogrumab 13
ublituximab 28
urelumab 17
ustekinumab 25
utomilumab 25
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 15
vantictumab 20
vanucizumab2 23
vanucizumab 25
varlilumab 12
vatelizumab 20
vedolizumab 25
veltuzumab 15
vesencumab 12
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 33
xentuzumab 16
zatuximab 36
